Viewing Study NCT06259669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-28 @ 2:58 AM
Study NCT ID: NCT06259669
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2024-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pregnancy Related View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ruxolitinib View
None Atopic Dermatitis View
None pruritus View
None eczema View
None topical therapy View
None JAK inhibitor View